Jin Medical International Ltd (ZJYL)

Jin Medical International Ltd. is a healthcare equipment and supplies company whose common shares trade on NASDAQ under the ticker ZJYL. The company develops, manufactures, and sells wheelchair products and related living aids for people with disabilities, older adults, and individuals recovering from injury. Its product range includes wheelchairs and components such as wheels and brakes, along with oxygen concentrators, bath aids, rehabilitative devices, and shared-wheelchair infrastructure. The company also markets oxygen chambers, beauty instruments, shampoo devices, and nano thermal therapy chambers. Founded in 2006 and based in Changzhou, China, Jin Medical International serves customers in Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and other international markets. It operates as a subsidiary of Jolly Harmony Enterprises Limited.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-ZJYL
$1.58
-20.7% Downside
Overvalued
Not available
Not available
Weak
0.0%
February 2, 2027
133.1x
5.1x
7.9x
156.1 M
146.7 M
11.9%
82.7%
8.6
-593.5%
Valuation • Fair Value

Jin Medical International Ltd (NASDAQ-ZJYL) Fair Value by Valuation Model

Review the available estimates for Jin Medical International Ltd (NASDAQ-ZJYL), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.58

Estimated downside of 20.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.34

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.17

Classic Ben Graham valuation formula reference.

Comps Fair Value

$1.73

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for Jin Medical International Ltd (NASDAQ-ZJYL) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Jin Medical International Ltd (NASDAQ-ZJYL)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

19.725 M

Current operating scale indicator.

Revenue Forecast

20.687 M

Forward revenue estimate.

EBITDA

657.35 K

Current operating profitability reference.

EBITDA Forecast

2.086 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Jin Medical International Ltd (NASDAQ-ZJYL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Jin Medical International Ltd (NASDAQ-ZJYL)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-2.06

Intermediate zone that deserves monitoring.

Altman Z-Score

8.6

Relatively strong balance-sheet zone.

FCF / Net Income

-593.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Jin Medical International Ltd (NASDAQ-ZJYL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Jin Medical International Ltd (NASDAQ-ZJYL)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 2, 2027

Days to Earnings

137

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Jin Medical International Ltd (NASDAQ-ZJYL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Jin Medical International Ltd (NASDAQ-ZJYL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Jin Medical International Ltd (NASDAQ-ZJYL) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Jin Medical International Ltd (NASDAQ-ZJYL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Jin Medical International Ltd (NASDAQ-ZJYL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Jin Medical International Ltd (NASDAQ-ZJYL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Jin Medical International Ltd (NASDAQ-ZJYL) Stock FAQ

Data-supported answers about Jin Medical International Ltd (NASDAQ-ZJYL), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.58
Estimated downside 20.7%
Valuation Rating
Overvalued
Estimated downside of 20.7%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Jin Medical International Ltd (NASDAQ-ZJYL) is $1.58. This implies an estimated downside of 20.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 20.7% versus the current market price.

The current financial health read for Jin Medical International Ltd (NASDAQ-ZJYL) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Jin Medical International Ltd (NASDAQ-ZJYL) is February 2, 2027.

The latest available data indicates no current dividend yield for Jin Medical International Ltd (NASDAQ-ZJYL).

The current P/E ratio listed for Jin Medical International Ltd (NASDAQ-ZJYL) is 133.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Jin Medical International Ltd is 156.1 M.

The current enterprise value listed for Jin Medical International Ltd is 146.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Jin Medical International Ltd is NASDAQ-ZJYL, and the stock is listed on NASDAQ.

Jin Medical International Ltd (NASDAQ-ZJYL) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Jin Medical International Ltd is 11.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Jin Medical International Ltd is 82.7%. Free float helps investors understand how much of the share base is available for public trading.